BIIB logo

BIIB
Biogen Inc

18,586
Mkt Cap
$29.22B
Volume
664,373.00
52W High
$202.41
52W Low
$119.18
PE Ratio
21.24
BIIB Fundamentals
Price
$200.98
Prev Close
$197.95
Open
$198.12
50D MA
$184.63
Beta
0.60
Avg. Volume
1.36M
EPS (Annual)
$8.79
P/B
1.57
Rev/Employee
$1.27M
$28,730.03
Loading...
Loading...
News
all
press releases
DNLI Q1 Loss Narrower Than Expected, Avlayah Approval Boosts Prospects
Denali narrows its Q1 loss and gains FDA approval for Avlayah, the first new Hunter syndrome treatment option in nearly 20 years.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Update on FDA Priority Review of LEQEMBI IQLIK (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease
Update on FDA Priority Review of LEQEMBI IQLIK (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease Update on FDA Priority Review of LEQEMBI IQLIK (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease PR Newswire TOKYO and...
PR Newswire·5d ago
News Placeholder
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...
PR Newswire·5d ago
News Placeholder
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational...
Business Wire·5d ago
News Placeholder
Biogen Inc. $BIIB Shares Sold by Horizon Investments LLC
Horizon Investments LLC decreased its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 71.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,382 shares of the biotechnology company's stock after selli...
MarketBeat·7d ago
News Placeholder
Comerica Bank Sells 14,195 Shares of Biogen Inc. $BIIB
Comerica Bank cut its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 42.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned...
MarketBeat·8d ago
News Placeholder
Mitsubishi UFJ Trust & Banking Corp Cuts Stake in Biogen Inc. $BIIB
Mitsubishi UFJ Trust & Banking Corp lowered its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 22.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,318 shares of the biot...
MarketBeat·10d ago
News Placeholder
Artemis Investment Management LLP Buys Shares of 226,845 Biogen Inc. $BIIB
Artemis Investment Management LLP acquired a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 226,845 shares of the biotechnology com...
MarketBeat·10d ago
News Placeholder
Biogen (NASDAQ:BIIB) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised shares of Biogen from a 'hold' rating to a 'buy' rating in a report on Saturday...
MarketBeat·11d ago
News Placeholder
Rothschild & Co Redburn Forecasts Strong Price Appreciation for Biogen (NASDAQ:BIIB) Stock
Rothschild & Co Redburn increased their price target on shares of Biogen from $180.00 to $190.00 in a report on Thursday...
MarketBeat·11d ago
<
1
2
...
>

Latest BIIB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.